Comparative Analysis of MAR and Terminator Elements in Controlling Stable EPO Expression in CHO-K1 Cells
Advanced Pharmaceutical Bulletin · 29.06.2026
DOI: 10.34172/apb.45955 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Pharmaceutical Bulletin, online erschienen am 29.06.2026. Verfasst von Fatemeh Jalali und 5 weiteren Autor:innen. Beteiligte Einrichtung: Medical Cellular and Molecular Research Center, Golestan University of Medical Sciences, Gorgan, Iran. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Purpose
Modulating chromatin organization and post-transcriptional regulation are critical for improving recombinant protein production . The human β-globin MAR (β-MAR) enhances transgene expression through nuclear matrix tethering, whereas the β-globin terminator (β-TERM) is implicated in transcriptional termination . However, their combined effects, particularly in stable erythropoietin (EPO) expression in CHO-K1 cells, remain less understood.
Methods
A codon-optimized EPO sequence were cloned into four expression plasmids. Stable polyclonal CHO-K1 cell pools were generated and assessed for transgene copy number, steady-state mRNA abundance, and EPO secretion . In parallel, in silico RNA-binding protein (RBP) profiling was performed for the polyA signal and β-TERM, followed by protein–protein interaction network analysis, hub-gene identification, and functional enrichment to elucidate post-transcriptional regulatory mechanisms.
Results
Incorporation of β-MAR resulted in remarkable EPO expression, yielding approximately 15 gene copies per cell, a 5.3-fold increase in mRNA abundance, and an EPO titer of 28.3 mIU/mL (3.4-fold over control). In contrast, the β-TERM element alone exerted minimal effects on protein output, while the combined β-MAR+β-TERM construct showed intermediate performance, suggesting partial attenuation of β-MAR activity. Network analysis of RBPs associated with poly(A) and β-TERM sequences revealed a highly interconnected post-transcriptional regulatory network enriched in RNA processing and stability factors. Notably, HNRNPK, HNRNPA2B1, U2AF2, FUS, and CELF1 were identified as central hub genes, indicating that β-TERM predominantly influences RNA fate rather than directly enhancing translation.
Conclusion
These findings establish β-MAR as a dominant chromatin-level enhancer of stable EPO expression in CHO cells and demonstrate that β-TERM engages RBP-centered post-transcriptional networks in a context-dependent and non-additive manner. This integrative analysis provides mechanistic insight for the rational design of expression cassettes in mammalian cell engineering and biopharmaceutical production.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Cellular and Molecular Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
- Department of Medical Biotechnology, Faculty of Advanced Medical Technologies, Golestan University of Medical Sciences, Gorgan, Iran.
- Department of Plant Breeding and Biotechnology, College of Plant Production, Gorgan University of Agricultural Sciences and Natural Resources, Gorgan, Iran.
- Arya Tina Gene (ATG) Biopharmaceutical Company, Gorgan, Iran.
ORCID-Profile: Fatemeh Jalali, Majid Shahbazi
Zitieren
APA
Jalali, F., Abdoli, S., Shamsabadi, F., Yamchi, A., Kianmehr, A., & Shahbazi, M. (2026). Comparative Analysis of MAR and Terminator Elements in Controlling Stable EPO Expression in CHO-K1 Cells. Advanced Pharmaceutical Bulletin. https://doi.org/10.34172/apb.45955
Vancouver
Jalali F, Abdoli S, Shamsabadi F, Yamchi A, Kianmehr A, Shahbazi M. Comparative Analysis of MAR and Terminator Elements in Controlling Stable EPO Expression in CHO-K1 Cells. Advanced Pharmaceutical Bulletin. 2026. doi:10.34172/apb.45955
BibTeX
@article{Jalali2026,
author = {Jalali, Fatemeh and Abdoli, Shahriyar and Shamsabadi, Fatemeh and Yamchi, Ahad and Kianmehr, Anvarsadat and Shahbazi, Majid},
title = {Comparative Analysis of MAR and Terminator Elements in Controlling Stable EPO Expression in CHO-K1 Cells},
journal = {Advanced Pharmaceutical Bulletin},
year = {2026},
doi = {10.34172/apb.45955}
}
EUVIMED